Bridgeway Capital Management’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Bridgeway Capital Management’s Portfolio BSPM Stock Details BSPM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-6,286	Closed	-$71K	–	1548
2014 Q3	$71K	Buy	+6,286	New	+$70K	﹤0.01%	1446

Other funds holding BSPM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bridgeway Capital Management's BSPM Position: Q4 2014 in Review

Bridgeway Capital Management sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q4 2014, closing a stake of 6,286 shares — an estimated $71K sold.

Bridgeway Capital Management first reported a position in BSPM in Q3 2014 and held it in 1 quarter. The position peaked at $71K in Q3 2014. 7 funds tracked by Wall St. Rank hold BSPM as of Q4 2014.

Bridgeway Capital Management reported no remaining Biostar Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
Bridgeway Capital Management sold 6,286 Biostar Pharmaceuticals, Inc. shares in Q4 2014, an estimated $71K.
Bridgeway Capital Management first reported a position in Biostar Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
Bridgeway Capital Management's Biostar Pharmaceuticals, Inc. position peaked at $71K in Q3 2014.
7 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q4 2014.

Based on Bridgeway Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.